Pfizer to go it alone with Exubera
January 16, 2006Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin
Pfizer has paid $1.3 billion to buy out its marketing partner’s stake in new inhaled diabetes drug Exubera.The US company …
Gene discovery offers new diabetes drug target hope
January 16, 2006Research and Development
A gene thought to be present in around 20% of type II diabetes patients has been identified, opening up the …
Unfamiliar territory
January 13, 2006At this year's NHS Confederation conference in June, the most debated corridor question was whether or not there would be …
Patients unaware as flagship NHS choice scheme launched
January 12, 2006Primary Care Trusts across England have launched an unprecedented marketing campaign to promote the new NHS choice agenda to patients.From …
Packer Forbes wins Remicade and Altana accounts
January 12, 2006Medical Communications
Packer Forbes has won new accounts from Schering-Plough for the arthritis treatment Remicade and from Altana Pharma for the company's …
Bayer buys hypertension drug rights from GSK
January 12, 2006Sales and Marketing
Bayer has bought the rights to market the hypertension drug telmisartan in a number of European markets from current licence …
Action needed on prostate cancer services
January 12, 2006Patients with prostate cancer are a lower NHS priority than those with other major cancers, despite the disease's status as …
PCT merger plans ‘ill conceived’
January 12, 2006Government plans for a radical restructuring of the NHS have been condemned in a new report by a committee of …
New dawn or beginning of the end? Medicare D comes of age
January 12, 2006Sales and Marketing
Millions of Americans woke up on 1 January 2006 and found themselves in an unfamiliar position having their prescription medicine …
GlaxoSmithKline considering Serono acquisition
January 12, 2006Sales and Marketing
GlaxoSmithKline is understood to be considering the acquisition of Europe's biggest biotech company Serono, currently worth around $12 billion.Serono's chief …
Wanted: Innovative drugs
January 12, 2006Research and Development prix galien
When the UK government last month announced a series of measures to boost research and development in the NHS, its …
Programme exposes counterfeit dangers
January 12, 2006Manufacturing and Production
An undercover investigation by a TV documentary team has uncovered serious flaws in the policing of UK pharmaceutical wholesaling and …
AstraZeneca buys UK cancer research firm
January 4, 2006Research and Development
AstraZeneca has bought a small UK biotech company KuDOS which specialises in cutting edge cancer research.AstraZeneca made its name in …
Woman wins right to Herceptin trial
December 22, 2005A woman with breast cancer has been granted the right to take her PCT to court for barring access to …
Politics and Healthcare – still a volatile mix
December 22, 2005Politics and the provision of healthcare are, it is generally agreed, ultimately inseparable; but their frequent interactions are a continual …
Bird flu tops 2005 global health concerns
December 22, 2005Sales and Marketing
A survey conducted by the World Health Organisation has confirmed concerns over a possible bird flu pandemic as the year's …
Tamiflu-resistant bird flu found
December 22, 2005Sales and Marketing
A report of two cases of bird flu which proved resistant to treatment with Tamiflu have been reported in the …
FDA approves Bayer’s kidney cancer drug
December 22, 2005Sales and Marketing
Bayer's Nexavar has become the first treatment in more than ten years to receive approval in the US for the …
Pfizer lifted by Lipitor patent victory
December 20, 2005Sales and Marketing
Shares in Pfizer have risen after it saw off a patent challenge to Lipitor, its biggest selling drug.Lipitor generates around …
An Inspector Calls
December 20, 2005I have become a pharmacovigilance bore within my company – a prophet of doom. It is worse than that, because …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
